2020
DOI: 10.1016/j.biopha.2019.109599
|View full text |Cite
|
Sign up to set email alerts
|

Tripterygium and its extracts for diabetic nephropathy: Efficacy and pharmacological mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
24
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 71 publications
1
24
0
Order By: Relevance
“…However, its toxicity limits its clinical application. With the development of various biotechnologies, TW and its extracts have been recognized as a key alternative intervention measures for the treatment of DN in the 2014 Consensus on Prevention of Diabetic Nephropathy in China, and its efficacy has been confirmed in many experiments ( Huang et al, 2020 ). Evidence-based medicine research shows that TW can effectively reduce proteinuria, serum creatinine, and blood urea nitrogen levels, and increase the effective rate ( Hong et al, 2016 ; Wang D. et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, its toxicity limits its clinical application. With the development of various biotechnologies, TW and its extracts have been recognized as a key alternative intervention measures for the treatment of DN in the 2014 Consensus on Prevention of Diabetic Nephropathy in China, and its efficacy has been confirmed in many experiments ( Huang et al, 2020 ). Evidence-based medicine research shows that TW can effectively reduce proteinuria, serum creatinine, and blood urea nitrogen levels, and increase the effective rate ( Hong et al, 2016 ; Wang D. et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…Also, it is widely recognized that MAPKs signaling pathway can be activated by HG or diabetes, thus contributing to DN 27,28 . It has been reported in a number of studies that a variety of natural products, including tripterygium 29 , ginsenoside 30 , and oridonin 31 , could inhibit inflammatory response in DN through the downregulation of MAPKs pathway. Herein, it was demonstrated that ISL inhibited the MAPKs pathways activated in STZ-induced DN and HG-challenged NRK-52E cells (Figs.…”
Section: Discussionmentioning
confidence: 99%
“…It not only lowers blood pressure but also reduces the proteinuria level [ 7 ]. Traditional Chinese medicine also has provided effective treatment for DN [ 8 ]. However, the therapeutic mechanism of DN remains unclear.…”
Section: Introductionmentioning
confidence: 99%